Current research suggests that low adiponectin level is linked with poor CRC outcome and studies that suggest a possible correlation between higher levels of adiponectin and improved overall outcome in CRC [11, 36, 37]. The gene discussed is ADIPOQ; the disease is colorectal carcinoma.